LXEO
Lexeo Therapeutics, Inc.
3.40$
-3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +155.5% | +52.5% | -9.9% | -9.4% | -15.5% | -14.5% | +40.1% | -18.3% | +86.8% | -6.8% | +1.8% | |
| – | +219.7% | +59.4% | -10.6% | -10.0% | -20.9% | -16.5% | +33.0% | -8.8% | +47.4% | +6.6% | +8.5% | |
| – | +242.7% | +60.6% | -10.3% | -10.3% | -77.7% | -17.4% | +22.7% | +15.5% | +53.7% | +13.9% | +29.4% | |
| – | +242.7% | +60.6% | -10.3% | -10.3% | -22.6% | -17.8% | +33.1% | -69.2% | +343.4% | -60.5% | +195.0% | |
| – | -87.9% | +15.2% | -10.6% | +27.6% | -12.9% | +24.8% | +0.7% | -39.2% | -4.3% | -14.4% | +5.2% | |
| – | -25.2% | +25.5% | -12.7% | +42.1% | -14.8% | +34.9% | +2.5% | -45.3% | -2.7% | -15.6% | +10.6% | |
| – | -61.4% | +0.2% | +2.3% | +0.4% | -0.4% | -0.9% | +0.3% | +2.2% | -1.5% | +0.7% | -1.1% | |
| – | +42.9% | +13.3% | +34.2% | +46.4% | -24.0% | +86.7% | +67.1% | -76.7% | +4.3% | -31.3% | +25.3% | |
| – | – | +61.1% | -9.8% | -15.5% | -16.1% | -24.6% | +56.9% | -12.6% | +104.1% | -6.2% | +1.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.5% | +2.4% | +17.9% | +0.2% | +0.0% | +0.1% | +31.6% | +39.9% | +25.2% | +6.3% | +5.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.